Antithrombotic agents can be lifesavers for cardiac patients, but they present a conundrum for gastroenterologists who, as the prevalence of cardiovascular disease continues to grow, are seeing ever-greater numbers of patients at risk for gastrointestinal bleeding.
At the 2020 virtual meeting of the American College of Gastroenterology, Neena S. Abraham, MD, MSc, discussed an area of study that evolved from an unmet need to a clinically relevant field: cardiogastroenterology.
“It seems fitting, in this year of change and unprecedented challenge, that we think beyond our usual clinical paradigms,” Abraham, a professor of medicine at Mayo Clinic in Scottsdale, Ariz., and the director of the ACG Institute for Clinical Research and Education, told attendees during the annual David Sun Lecture.